Impaired VEGF signaling can lead to endothelial dysfunction, decreased tissue perfusion, and ultimately contribute to insulin resistance.40,41 Also, the association between RHEB inhibition and increased T2D risk supports the critical role of mTORC1 signaling in controlling glucose metabolism. The gene discussed is RHEB; the disease is type 2 diabetes mellitus.